Showing posts with label angina. Show all posts
Showing posts with label angina. Show all posts

Tuesday, November 2, 2010

Plumbing paradigm might work!

I recently presented a morning report in my Clinic about preventive Cardiology...and I had mentioned about 'plumbing paradigm' ( relieving coronary blockage whenever we find one) does not make things better compared to a medical & lifestyle approach. I based this on two studies done on patients with stable coronary artery disease -

1.COURAGE trial - 2200 patients with stable CAD(ST depression or T wave inversion on resting ECG, inducible ischemia with exercise, or at least one coronary artery stenosis of at least 80% and angina. EF <30were excluded ). 2/3rds of pts had multivessel disease. Pts were randomised to PCI with bare metal stent Vs medical therapy. Over a period of nearly 5 years..there was no difference in primary outcome of all cause mortality, non fatal MI between 2 groups. Angina relief , stroke, hospitalisation for MI did not differ as well. But..a subgroup(n=314) were further enrolled to undergo nuclear study at baseline and after 1 year. PCI did show a significant reduction in ischemic myocardium compared to medical therapy.
2. BARI 2 trial - 2300 patients with type 2 diabetes and CAD(>50% stenosis of major coronary artery with +ve stress test or >70% stenosis with classic angina. Class 3 & 4 heart failure, creatinine>2 were excluded).Over a period of 5 years there was no significant difference between PCI/CABG  Vs medical therapy alone ...in terms of survival, MI, and angina. 


But ..recently ..the MASS 2 trial was published in Circulation -  a randomised controlled trial of 611 patients with CAD ( with proximal multivessel stenosis .70%, stable class 2 or 3 CHF, HTN or diabetes). Pts were randomised to either CABG or PCI with BMS or medical therapy alone. Follow up for 10 years showed a significant improvement in cardiovascular mortality, recurrent MI, angina ...compared to medical therapy.PCI was associated with an increased need for further revascularization, a higher incidence of myocardial infarction, and a 1.46-fold increased risk of combined events compared with CABG. A thing to note..is that majority of patients in this study had aither triple vessel disease or proximal LAD disease....and this is likely why CABG showed a great benefit. 


So.....based on these studies.....PCI /CABG may be superior to medical therapy in patients with stable multivessel disease( and the plumbing paradigm seems to work). But this cannot be generalized for others with stable and mild CAD ..where medical therapy has equal mortality and antianginal benefit as intervention...provided the disease is stable.

Thursday, September 9, 2010

Isosorbide mononitrate Vs dinitrate - what to use?

This post is due to the question asked by one of my clever interns. What is the difference between the nitrates, and how can we apply that in practice based on the evidence we have.
We use three intrates- nitroglycerine, isosorbide mononitrate(ISMN), isosorbidedinitrate(ISDN). They are used widely for stable & unstable angine , heartfailure, and acute MI.  ISMN & ISDN both have to be denitrified to nitric oxide and cause vasodilation of venules and arteioles.

ISDN - has extensive first pass metabolism in the liver, and its half life is 40 min. Its major metabolites are isosorbide 2 mononitrate & isosorbide 5 mononitrate with half lives of 2 & 4 hrs respectively.
In a study done on pts with tid dose of ISDN with a 14 hr drug free interval, the excercise capacity improved after the first dose. Another study with same dose showed antianginal effects decreased progressively after the 2nd & 3rd dose likely due to tolerance. There is a sustained release ISDN when used at the max dose of 80mg bid ..causes tolerence,but when administered less than 12 hrs apart with a long drug free period...the antianginal effect was ok. One of the major studies of black pts with heart failure A-HEFT trial showed mortality benefit in adding ISDN with hydralazine.This made ACC to include ISDN in their 2009 guidelines for heart failure.

ISMN - doesn't undergo first pass hepatic metabolism.half life is around 4-6 hrs.It is primarily used in the management of chronic stable angina. It is not FDA-approved for treating heart failure. Standard formulations are 20 & 40 mg ..and again when given in an eccentric fashion(less than 12 hrs between daytime doses)...tolerance seems to be less.There is an extended release ISMN given once a day which also gives antianginal efect.

Soooo...... ISMN is preferred for angina as its once daily administration, and does better with compliance. Its better to give the drug in the morning during the time pts are active..and leave them drug free during sleep.
ISDN is recommended for heart failure (especially useful in black people..along with hydralazine), and has to be given in n eccentric fashion ( 8 hrs apart i.e- at 9am & 5pm...and so a 16hr drug free interval) to prevent tolerance. If adherence is an issue..then ISMN can be used in an off label fashion.
Also its safe to taper slowly ..when stopping nitrates..to prevent rebound.